Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06827990 · ClinicalTrials.gov registry record · NA
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
A NA study of Aortic Dissection, sponsored by W.L.Gore & Associates.
- Recruiting
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 13
- Study locations
NCT06827990 is a NA study of Aortic Dissection that is actively recruiting participants, run by W.L.Gore & Associates. The registered enrollment target is 112 participants, below the 654-participant average among 11 other Aortic Dissection trials with a reported enrollment target (83% lower). The trial reports 13 study locations across 11 states.
The verdict
NCT06827990, a NA study of Aortic Dissection, is actively recruiting participants, sponsored by W.L.Gore & Associates.
- RECRUITING
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 13
- Study locations
Study Summary
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
Conditions Studied
Interventions
- DEVICE GORE® Ascending Stent Graft (ASG device)
Study Locations (13)
Ohio
- Cleveland Clinic - Cleveland
- Ohio Health Research Institute - Columbus
Texas
- The Methodist Hospital Houston - Houston
- Baylor Research Institute - Plano
Alabama
- University of Alabama at Birmingham - Birmingham
Florida
- University of Florida - Gainesville
Georgia
- Emory University School of Medicine - Atlanta
Illinois
- Northwestern Medicine - Chicago
Indiana
- Indiana University - Indianapolis
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2025-09-22 |
| Est. Completion | 2031-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06827990
The ClinicalTrials.gov registry entry for NCT06827990 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 654-participant average among 11 other Aortic Dissection trials with a reported enrollment target (83% lower). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Dissection appearing as the primary indexed condition, and to 1 intervention - of which GORE® Ascending Stent Graft (ASG device) is the first listed.
NCT06827990 reports 13 study locations spanning 11 distinct geographic areas - top geographies include Ohio, Texas, Alabama.
Frequently Asked Questions
What is clinical trial NCT06827990 about?
NCT06827990 is a clinical study titled "GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections". To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
What is the current status of trial NCT06827990?
This trial is currently recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2025-09-22. Estimated completion is 2031-09-01.
What conditions does trial NCT06827990 study?
This clinical trial studies the following conditions: Aortic Dissection.
What interventions are being tested in trial NCT06827990?
The interventions under investigation include: GORE® Ascending Stent Graft (ASG device) (DEVICE).
Who is sponsoring clinical trial NCT06827990?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06827990 being conducted?
This trial has 13 study locations across Alabama, Florida, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Dissection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
RECRUITING · NA
-
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
RECRUITING · NA
-
Feasibility of Endovascular Repair Of Ascending Aortic Pathologies
RECRUITING · NA
-
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
-
Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.